Standout Papers

Maraviroc for Previously Treated Patients with R5 HIV-1 Infection 2008 2026 2014 2020 560
  1. Maraviroc for Previously Treated Patients with R5 HIV-1 Infection (2008)
    Roy M. Gulick, Jacob Lalezari et al. New England Journal of Medicine

Citation Impact

6 by Nobel laureates 15 from Science/Nature 61 standout
Sub-graph 1 of 23

Citing Papers

Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
2024 Standout
Debaryomyces is enriched in Crohn’s disease intestinal tissue and impairs healing in mice
2021 StandoutScience
2 intermediate papers

Works of Howard Mayer being referenced

Effects of Maraviroc and Efavirenz on Markers of Immune Activation and Inflammation and Associations with CD4+ Cell Rises in HIV-Infected Patients
2010
Maraviroc for Previously Treated Patients with R5 HIV-1 Infection
2008 Standout

Author Peers

Author Infectious Diseases Virology Epidemiology Last Decade Papers Cites
Howard Mayer 1019 1150 435 15 1.7k
H. Schröder 10 353
Javier Marín‐Prida 19 1 6 20 551
Scott A. Asher 4 7 13 318
Ioana Boghian 2 13 217
João Eduardo Azevedo Ramos da Silva 1 21 759

All Works

Loading papers...

Rankless by CCL
2026